CUDC 427 in combination with standard capecitabine chemotherapy in patients with HER2-negative, advanced breast cancer
Latest Information Update: 11 Dec 2012
At a glance
- Drugs CUDC 427 (Primary) ; Antineoplastics; Capecitabine
- Indications Advanced breast cancer
- Focus Adverse reactions; Therapeutic Use
- 11 Dec 2012 New trial record